Superbug and viral pathogen treatment developer Recce Pharmacetical (ASX:RCE)’s unapproved drug R327 has successfully saved a patient suffering a life-threatening illness.
Despite not undertaking clinical trials, nasal treatment R327 was accessible to the individual via Category A of the Therapeutic Goods Administration special access scheme. Recce (ASX:RCE) intends to proceed with clinical trials for the product.
The news has shot Recce’s shares up 5.1 per cent to $1.03
Copyright 2021 – Finance News Network
30 Jun 2020 - WiseTech Global (ASX:WTC) has been informed that RealWise Holdings Pty Ltd, a company controlled by WiseTech Global Founder and CEO, Richard White, has sold 2.4 million shares (approximately 0.76 per cent of the total issued capital of WiseTech Global).
15 Dec 2020 - Contracting group MACA (ASX:MLD) is set to buy Downer EDI’s Mining West business for an acquisition value of $175 million with approximately $30 million from the unwinding of working capital balances.
27 Apr 2020 - Australia’s leading grower, packer and marketer of fresh fruit and vegetables Costa Group Holdings (ASX:CGC) today announced that after an extensive search and selection process, Wayne Johnston has been appointed to the role of Chief Financial Officer, commencing from 29th June 2020.
29 Apr 2021 - A snapshot of the top stock news for the hour, featuring Novatti (ASX:NOV), Woolworths (ASX:WOW), NRW (ASX:NWH) & Unibail-Rodamco-Westfield (ASX:URW).
25 Sep 2019 - 1300SMILES (ASX:ONT) has commented on its interest in acquiring the Maven Dental Group from NZX listed Abano Healthcare Group Limited (NZX:ABA) confirming it is in confidential discussions with Abano.
03 Sep 2020 - Starpharma (ASX:SPL) has been awarded $1 million in matched funding by the Australian Government’s Medical Research Future Fund (MRFF) Biomedical Translation Bridge (BTB) Program.
